JP2005034131A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005034131A5 JP2005034131A5 JP2003376376A JP2003376376A JP2005034131A5 JP 2005034131 A5 JP2005034131 A5 JP 2005034131A5 JP 2003376376 A JP2003376376 A JP 2003376376A JP 2003376376 A JP2003376376 A JP 2003376376A JP 2005034131 A5 JP2005034131 A5 JP 2005034131A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- peptide
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims 31
- 125000003275 alpha amino acid group Chemical group 0.000 claims 24
- 150000002148 esters Chemical class 0.000 claims 24
- 150000001408 amides Chemical class 0.000 claims 23
- 239000003814 drug Substances 0.000 claims 9
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- 102000005962 receptors Human genes 0.000 claims 8
- 108020003175 receptors Proteins 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims 6
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims 6
- 238000012216 screening Methods 0.000 claims 6
- 238000000034 method Methods 0.000 claims 4
- 230000019491 signal transduction Effects 0.000 claims 4
- 230000012292 cell migration Effects 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003376376A JP4404605B2 (ja) | 2002-11-07 | 2003-11-06 | 新規なｆｐｒｌ１リガンドおよびその用途 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002324189 | 2002-11-07 | ||
| JP2002367119 | 2002-12-18 | ||
| JP2003059073 | 2003-03-05 | ||
| JP2003191359 | 2003-07-03 | ||
| JP2003376376A JP4404605B2 (ja) | 2002-11-07 | 2003-11-06 | 新規なｆｐｒｌ１リガンドおよびその用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005034131A JP2005034131A (ja) | 2005-02-10 |
| JP2005034131A5 true JP2005034131A5 (enExample) | 2006-12-14 |
| JP4404605B2 JP4404605B2 (ja) | 2010-01-27 |
Family
ID=34222621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003376376A Expired - Fee Related JP4404605B2 (ja) | 2002-11-07 | 2003-11-06 | 新規なｆｐｒｌ１リガンドおよびその用途 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4404605B2 (enExample) |
-
2003
- 2003-11-06 JP JP2003376376A patent/JP4404605B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Verhagen et al. | Cell death regulation by the mammalian IAP antagonist Diablo/Smac | |
| US7897569B2 (en) | Use of HMGB fragments as anti-inflammatory agents | |
| ES2566830T3 (es) | Péptido capaz de extender la semivida de péptido de interés en plasma | |
| JP2013505221A (ja) | 長時間作用性ｙ２受容体アゴニスト | |
| Sluka et al. | Importance of minor-groove contacts for the recognition of DNA by the binding domain of Hin recombinase | |
| JPH11500107A (ja) | 成長ホルモン放出特性をもつ化合物 | |
| CN1318069A (zh) | 因子VIIa抑制剂 | |
| TW201018479A (en) | Amylin derivatives | |
| JP2011502964A5 (enExample) | ||
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| KR20080003350A (ko) | α-헬릭스 유사물 및 섬유증 치료에 관한 방법 | |
| DE50304608D1 (de) | Sandwich-immunoassay zur bestimmung von proanp-teilpeptiden | |
| JP2006514820A5 (enExample) | ||
| JP2010512326A5 (enExample) | ||
| JPH10502091A (ja) | ＰＴＨまたはＰＴＨｒＰアンタゴニスト | |
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| DE4402756A1 (de) | Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine | |
| JP2005034131A5 (enExample) | ||
| RU2012107290A (ru) | Мотилин-подобное пептидное соединение, обладающее приданной ему трансмукозальной абсорбционной способностью | |
| ATE294816T1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| JP2008505852A5 (enExample) | ||
| WO2007126111A1 (ja) | アミロイドβ線維化阻害ペプチド | |
| JP2008522632A5 (enExample) | ||
| JP2006510360A5 (enExample) | ||
| JP2008538501A5 (enExample) |